Next Science Ltd (AU:NXS) has released an update.
Next Science Limited has successfully passed all resolutions during its 2024 Annual General Meeting, with the support of the majority of its shareholders through a poll. The company, known for its innovative XBIO™ technology aimed at combating biofilm-based infections, continues to move forward with strong backing from its investors. The AGM results underscore the confidence in Next Science’s strategy and leadership, as it maintains 100% ownership of the patented XBIO™ technology.
For further insights into AU:NXS stock, check out TipRanks’ Stock Analysis page.
